Healthcare Sector Actividad de insiders

Sigue las compras y ventas de insiders en acciones de Healthcare. Descubre qué ejecutivos compran, la actividad neta de insiders y el % del capital flotante negociado en 3,224 empresas.
La información que se muestra en esta pantalla tiene fines meramente informativos y no constituye asesoramiento financiero. No recomendamos ninguna inversión específica basándonos en estos criterios.
Empresas
Datos
Suscríbase para acceder a todos los datos.
Compañía Sector empresarial Capitalización de mercado ($) # Compras netas de insiders Valor neto de la compra ($) % de flotación comprada % de acciones en manos de insiders
Healthcare Services Large (15.5bn) 0 No hay actividad — 15–50%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (15.4bn) 0 No hay actividad — 50%+
US Revvity Inc (RVTY)
Healthcare Services Large (14.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (14.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (14.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.8bn) -1–5 -$100M+ -15–50% 0–15%
DE Sartorius AG (SRT)
Healthcare Services Large (13.7bn) 0 No hay actividad — 50%+
Healthcare Services Large (13.5bn) 0 No hay actividad — 15–50%
US Exelixis Inc (EXEL)
Pharmaceuticals & Medical Research Large (13.4bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (13.4bn) 0 No hay actividad — 50%+
Pharmaceuticals & Medical Research Large (13.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (13.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (13.2bn) 0 No hay actividad — 15–50%
FI Orion Oyj (ORNBV)
Pharmaceuticals & Medical Research Large (13.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (12.9bn) 0 No hay actividad — 50%+
US Penumbra Inc (PEN)
Healthcare Services Large (12.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (12.7bn) 0 No hay actividad — 15–50%
IE ICON PLC (ICLR)
Pharmaceuticals & Medical Research Large (12.7bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (12.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (12.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.4bn) 0 No hay actividad — 50%+
Healthcare Services Large (12.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (12.3bn) 0 No hay actividad — 0–15%
FR Abivax SA (ABVX)
Pharmaceuticals & Medical Research Large (12.3bn) 0 No hay actividad — 0–15%
Healthcare Services Large (12.2bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (12.1bn) -1–5 -$1M–$10M -0–15% 0–15%
US MyoKardia Inc (MYOK)
Pharmaceuticals & Medical Research Large (12.0bn) 0 No hay actividad — 0–15%
Healthcare Services Large (11.7bn) 0 No hay actividad — 0–15%
Healthcare Services Large (11.7bn) 0 No hay actividad — 0–15%
Healthcare Services Large (11.6bn) 0 No hay actividad — 15–50%
US Catalent Inc (CTLT)
Pharmaceuticals & Medical Research Large (11.5bn) 0 No hay actividad — 0–15%
Healthcare Services Large (11.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US DaVita Inc (DVA)
Healthcare Services Large (11.3bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (11.3bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (11.0bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (10.9bn) 0 No hay actividad — 15–50%
US Glaukos Corp (GKOS)
Healthcare Services Large (10.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (10.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (10.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (10.3bn) 0 No hay actividad — 0–15%
US Insulet Corp (PODD)
Healthcare Services Large (10.3bn) 1–5 $100K–$1M 0–15% 0–15%
Healthcare Services Large (10.2bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Large (10.2bn) 0 No hay actividad — 0–15%
Healthcare Services Large (10.2bn) 0 No hay actividad — 0–15%
Healthcare Services Large (10.2bn) 0 No hay actividad — 0–15%
AU Cochlear Ltd (COH)
Healthcare Services Large (10.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Large (10.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Repligen Corp (RGEN)
Healthcare Services Mid (10.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (9.9bn) 1–5 $100M+ 0–15% 50%+
Pharmaceuticals & Medical Research Mid (9.8bn) -6–10 -$10M–$100M -0–15% 15–50%
US Nuvalent Inc (NUVL)
Pharmaceuticals & Medical Research Mid (9.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (9.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (9.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (9.6bn) 0 No hay actividad — 15–50%
DK Demant A/S (DEMANT)
Healthcare Services Mid (9.5bn) 0 $100K–$1M 0–15% 50%+
US Masimo Corp (MASI)
Healthcare Services Mid (9.4bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (9.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.2bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (9.1bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (9.1bn) 0 No hay actividad — 0–15%
Healthcare Services Mid (8.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (8.9bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.8bn) -6–10 -$1M–$10M -0–15% 0–15%
US ImmunoGen Inc (IMGN)
Pharmaceuticals & Medical Research Mid (8.7bn) 0 No hay actividad — 0–15%
US Mylan NV (MYL)
Pharmaceuticals & Medical Research Mid (8.6bn) 0 No hay actividad — 0–15%
US Bruker Corp (BRKR)
Healthcare Services Mid (8.6bn) -1–5 -$100K–$1M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (8.4bn) 0 No hay actividad — 0–15%
IE Alkermes Plc (ALKS)
Pharmaceuticals & Medical Research Mid (8.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (8.2bn) 0 No hay actividad — 50%+
US Liquidia Corp (LQDA)
Pharmaceuticals & Medical Research Mid (8.0bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (7.9bn) 0 No hay actividad — 0–15%
US Vaxcyte Inc (PCVX)
Pharmaceuticals & Medical Research Mid (7.8bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (7.7bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (7.6bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (7.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (7.4bn) 0 No hay actividad — 15–50%
IN Aurobindo Pharma Ltd (AUROPHARMA)
Pharmaceuticals & Medical Research Mid (7.4bn) 0 No hay actividad — 50%+
Healthcare Services Mid (7.3bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Mid (7.1bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (7.1bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No hay actividad — 0–15%
ES Grifols SA (GRF)
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No hay actividad — 15–50%
Pharmaceuticals & Medical Research Mid (7.1bn) 0 No hay actividad — 50%+
US Chemed Corp (CHE)
Healthcare Services Mid (7.1bn) -1–5 -$1M–$10M -0–15% 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (7.0bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Mid (7.0bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (7.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (7.0bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No hay actividad — 50%+
US Merus NV (MRUS)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No hay actividad — 50%+
NL Qiagen NV (QIA)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No hay actividad — 0–15%
US Medicines Co (MDCO)
Pharmaceuticals & Medical Research Mid (6.8bn) 0 No hay actividad — —
Pharmaceuticals & Medical Research Mid (6.8bn) 1–5 $10M–$100M 0–15% 0–15%
US Arcellx Inc (ACLX)
Pharmaceuticals & Medical Research Mid (6.7bn) 0 No hay actividad — 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals & Medical Research Mid (6.5bn) 0 No hay actividad — 0–15%
Pharmaceuticals & Medical Research Mid (6.4bn) 0 No hay actividad — 0–15%
US Erasca Inc (ERAS)
Pharmaceuticals & Medical Research Mid (6.4bn) 0 No hay actividad — 0–15%